CUAMC
KNTE
China Universal Asset Management Company’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,201
| Closed | -$1.68K | – | 496 |
|
|
2023
Q3 | $1.68K | Buy |
1,201
+590
| +97% | +$826 | ﹤0.01% | 440 |
|
|
2023
Q2 | $1.85K | Buy |
611
+13
| +2% | +$39 | ﹤0.01% | 430 |
|
|
2023
Q1 | $3.74K | Buy |
598
+150
| +33% | +$938 | ﹤0.01% | 395 |
|
|
2022
Q4 | $2.73K | Buy |
448
+34
| +8% | +$207 | ﹤0.01% | 353 |
|
|
2022
Q3 | $5K | Buy |
+414
| New | +$5K | ﹤0.01% | 281 |
|